MOLECULIN BIOTECH INC (MBRX)
US60855D3098 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to MBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.7. This target is 605.53% above the current price.
MBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MBRX.
In the previous month the buy percentage consensus was at a similar level.
MBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-12 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-26 | Maxim Group | Maintains | Buy -> Buy |
| 2023-12-14 | HC Wainwright & Co. | Initiate | Buy |
| 2023-04-18 | Roth MKM | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |